Financhill
Sell
32

SLN Quote, Financials, Valuation and Earnings

Last price:
$6.18
Seasonality move :
-4.72%
Day range:
$5.99 - $6.29
52-week range:
$1.97 - $8.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
144.02x
P/B ratio:
3.92x
Volume:
159K
Avg. volume:
295.9K
1-year change:
-12.29%
Market cap:
$290M
Revenue:
$43.3M
EPS (TTM):
-$2.38

Earnings Data

Next earnings date for SLN
Feb 26
2026
Most recent earnings per share
-$0.44
Missed by $0.23
(Nov 6/2025)
Consensus Estimate
-$0.21
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SLN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $4.1M -- -- -$0.49 --
11/06/2025 Q3 $4.4M $158K -$0.44 -$0.21 -$0.23
08/15/2025 Q2 $4.6M $226.7K -$0.59 -$0.21 -$0.38
05/22/2025 Q1 $4.2M $142.5K -$0.61 -$0.42 -$0.19
02/27/2025 Q4 $4.8M -- -- -$0.25 --
11/14/2024 Q3 $3.9M $1.5M -$0.75 -$0.13 -$0.62
08/15/2024 Q2 $12.4M $754.5K -$0.42 -$0.11 -$0.31
05/16/2024 Q1 $4.5M $15.7M -$0.05 -$0.17 $0.11
03/13/2024 Q4 $11.6M $2.6M -$0.45 -$0.21 -$0.24
11/14/2023 Q3 $3.1M $3.5M -$0.28 -$0.38 $0.10
08/16/2023 Q2 -- $11.4M -$0.36 -- --
05/16/2023 Q1 -- $13.8M -$0.34 -- --
03/15/2023 Q4 -- $5.6M -$0.45 -- --
11/10/2022 Q3 -- $4M -$0.25 -- --
09/27/2022 Q2 -- $4.6M -$0.50 -- --
05/16/2022 Q1 -- $7.7M -$0.34 -- --
03/17/2022 Q4 -- $4.7M -$0.43 -- --
11/16/2021 Q3 -- $4.2M -$0.45 -- --
06/30/2021 Q2 -- $3.7M -$0.54 -- --
03/31/2021 Q1 -- $4.3M -$0.40 -- --
12/31/2020 Q4 -- $3.4M -$0.67 -- --
09/30/2020 Q3 -- $2.6M -$0.42 -- --

Silence Therapeutics Plc Earnings Questions

  • How Much did Silence Therapeutics Plc Generate in Revenue Last Quarter?

    Silence Therapeutics Plc reported $158K worth of top line sales in its most recent quarter.

  • Did Silence Therapeutics Plc Beat Earnings Last Quarter?

    Silence Therapeutics Plc announced earnings per share of -$0.44 which represents a miss of analyst forecast a -$0.21 per share.

  • Is Silence Therapeutics Plc Profitable?

    Silence Therapeutics Plc reported -$20.4K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Silence Therapeutics Plc EPS Next Year?

    Silence Therapeutics Plc's earnings are forecast to decrease from -$0.98 per share to -$0.79 per share next year representing a decrease of -35.7%.

  • When is Silence Therapeutics Plc's Earnings Date?

    Silence Therapeutics Plc's next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock